(S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one hydrochloride(CAS: 898543-06-1)

This chemical compound (CAS: 898543-06-1) is a morpholinone derivative featuring a complex structure with an aminomethyl group and an oxazolidinone ring. It is a hydrochloride salt, which enhances its solubility and stability. The compound is commonly used in pharmaceutical research and synthesis due to its functional groups, which may participate in various chemical reactions. Its molecular formula is C17H21N3O4·HCl, and it exhibits properties typical of nitrogen-containing heterocyclic compounds, such as reactivity and potential biological activity.

This compound (CAS: 898543-06-1) is primarily utilized in pharmaceutical research as an intermediate for drug development, particularly in the synthesis of bioactive molecules. Its structure may be relevant in creating compounds with antimicrobial, antiviral, or anti-inflammatory properties. It is also employed in chemical synthesis and industrial applications where functional group versatility is required. Additionally, it serves as a research tool for studying molecular interactions and reaction mechanisms.

Safety of this compound (CAS: 898543-06-1) depends on proper handling. As a chemical compound, it may pose toxicity risks if inhaled, ingested, or contacted with skin, necessitating adherence to chemical safety standards. Precautions include wearing protective gloves, goggles, and a lab coat, and working in a well-ventilated area. It is classified as a hazardous substance under OSHA guidelines, so users should follow established safety protocols to minimize exposure and ensure safe handling during experiments or industrial processes.

This compound (CAS: 898543-06-1) should be stored in a cool, dry place, ideally at 2-8°C, to maintain its chemical stability. It is sensitive to moisture and light, so storage in an airtight, dark container is essential. Keep it away from reactive materials and ensure proper ventilation. The hydrochloride salt form requires protection from humidity to prevent degradation, and storage conditions should comply with ICH guidelines for pharmaceutical intermediates.